Yuanlong Gu

744 total citations
38 papers, 578 citations indexed

About

Yuanlong Gu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yuanlong Gu has authored 38 papers receiving a total of 578 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 13 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Yuanlong Gu's work include RNA modifications and cancer (6 papers), Cancer-related molecular mechanisms research (5 papers) and Extracellular vesicles in disease (4 papers). Yuanlong Gu is often cited by papers focused on RNA modifications and cancer (6 papers), Cancer-related molecular mechanisms research (5 papers) and Extracellular vesicles in disease (4 papers). Yuanlong Gu collaborates with scholars based in China and United States. Yuanlong Gu's co-authors include Jian‐Ping Li, Hao Hu, Yanqiao Zhang, Cheng Jin, Guoqiang Lv, Shuli Tang, Xianming Yu, Ping‐Kun Zhou, Chun Zhang and Feng‐Lai Yuan and has published in prestigious journals such as PLoS ONE, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Yuanlong Gu

36 papers receiving 574 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yuanlong Gu China	15	336	199	114	54	50	38	578
Jinlong Li China	10	356 1.1×	199 1.0×	99 0.9×	27 0.5×	50 1.0×	12	641
Edward Șeclăman Romania	15	301 0.9×	167 0.8×	111 1.0×	19 0.4×	44 0.9×	51	571
Yingying Gong China	15	309 0.9×	164 0.8×	52 0.5×	26 0.5×	39 0.8×	32	522
Muhlis Akman Italy	10	202 0.6×	134 0.7×	105 0.9×	57 1.1×	58 1.2×	14	453
Sophie Duban‐Deweer France	12	471 1.4×	158 0.8×	62 0.5×	36 0.7×	62 1.2×	23	740
Miriam Butler Australia	11	246 0.7×	100 0.5×	72 0.6×	42 0.8×	54 1.1×	28	530
Xiangyu Zhou China	13	299 0.9×	120 0.6×	67 0.6×	56 1.0×	136 2.7×	43	638
Yingying Tong China	12	485 1.4×	258 1.3×	128 1.1×	31 0.6×	125 2.5×	44	790
Kyeong Jin Shin South Korea	10	506 1.5×	252 1.3×	90 0.8×	36 0.7×	79 1.6×	15	680

Countries citing papers authored by Yuanlong Gu

Since Specialization

Citations

This map shows the geographic impact of Yuanlong Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuanlong Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuanlong Gu more than expected).

Fields of papers citing papers by Yuanlong Gu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuanlong Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuanlong Gu. The network helps show where Yuanlong Gu may publish in the future.

Co-authorship network of co-authors of Yuanlong Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Yuanlong Gu. A scholar is included among the top collaborators of Yuanlong Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuanlong Gu. Yuanlong Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Enhong, et al.. (2025). Targeting the PI3K-AKT pathway to alleviate 6PPDQ-induced cognitive impairment associated with metabolic syndrome. Ecotoxicology and Environmental Safety. 302. 118711–118711. 1 indexed citations

Yue, Tao, Enhong Chen, Shuo Zhang, et al.. (2025). NAT10 promotes hepatocellular carcinoma progression by modulating the ac4C-DDIAS-PI3K-Akt axis. Scientific Reports. 15(1). 17286–17286. 1 indexed citations

Yang, Jun, et al.. (2024). Intestinal GSTpi deficiency exacerbates the severity of experimental hyperlipidemic acute pancreatitis. International Immunopharmacology. 137. 112363–112363. 2 indexed citations

Chen, Haiyan, Bo Wu, Shuo Zhang, et al.. (2024). Sex differences in mortality and liver‐related events in non‐alcoholic fatty liver disease: A systematic review and meta‐analysis. Liver International. 44(7). 1600–1609. 10 indexed citations

Chen, Haiyan, et al.. (2024). Physical activity and exercise in liver cancer. Liver Research. 8(1). 22–33. 2 indexed citations

Wu, Di, Bo Wu, Xiaohua Pan, et al.. (2023). Formononetin alleviates acute pancreatitis by reducing oxidative stress and modulating intestinal barrier. Chinese Medicine. 18(1). 78–78. 10 indexed citations

Gu, Yuanlong, Zhipeng Li, Xingli Zhang, et al.. (2023). Diagnostic value of combining preoperative inflammatory markers ratios with CA199 for patients with early-stage pancreatic cancer. BMC Cancer. 23(1). 227–227. 6 indexed citations

Li, Shijie, Xingli Zhang, Changjie Lou, Yuanlong Gu, & Juan Zhao. (2022). Preoperative peripheral blood inflammatory markers especially the fibrinogen-to-lymphocyte ratio and novel FLR-N score predict the prognosis of patients with early-stage resectable extrahepatic cholangiocarcinoma. Frontiers in Oncology. 12. 1003845–1003845. 7 indexed citations

Jin, Yan, Gang Wei, Linyou Wang, et al.. (2022). Design and development of novel fluorescence sensing material for exosome recognition. Colloids and Surfaces B Biointerfaces. 214. 112421–112421. 5 indexed citations

10.

Hu, Hao, et al.. (2021). NEAT1/miR-101-dependent Up-regulation of DNA-PKcs Enhances Malignant Behaviors of Pancreatic Ductal Adenocarcinoma Cells. Journal of Cancer. 12(18). 5622–5632. 7 indexed citations

11.

Hu, Hao, et al.. (2021). ACTR3 promotes cell migration and invasion by inducing epithelial mesenchymal transition in pancreatic ductal adenocarcinoma. Journal of Gastrointestinal Oncology. 12(5). 2325–2333. 8 indexed citations

12.

Zhou, Lisha, Jin Zhu, Wangyang Chen, et al.. (2020). Induction of NEDD8-conjugating enzyme E2 UBE2F by platinum protects lung cancer cells from apoptosis and confers to platinum-insensitivity. Cell Death and Disease. 11(11). 975–975. 21 indexed citations

13.

Wu, Xiaomin, et al.. (2020). <p>Gluconokinase IDNK Promotes Cell Proliferation and Inhibits Apoptosis in Hepatocellular Carcinoma</p>. OncoTargets and Therapy. Volume 13. 1767–1776. 3 indexed citations

14.

Jin, Cheng, et al.. (2018). The expressions of acid sensing ion channel 1a and activator protein-1 in hepatocellular carcinoma and their relationships with clinical features. Zhonghua gan-dan waike zazhi. 24(6). 376–380. 2 indexed citations

15.

Gu, Yuanlong, Juan Zhao, Qi Li, et al.. (2017). Influence of the number and interval of treatment cycles on cytokine-induced killer cells and their adjuvant therapeutic effects in advanced non-small-cell lung cancer (NSCLC). International Immunopharmacology. 50. 263–269. 8 indexed citations

16.

Hu, Hao, et al.. (2016). micorRNA-101 silences DNA-PKcs and sensitizes pancreatic cancer cells to gemcitabine. Biochemical and Biophysical Research Communications. 483(1). 725–731. 20 indexed citations

17.

Jin, Cheng, Qing‐Hai Ye, Feng‐Lai Yuan, et al.. (2015). Involvement of acid-sensing ion channel 1α in hepatic carcinoma cell migration and invasion. Tumor Biology. 36(6). 4309–4317. 43 indexed citations

18.

He, Yuxiang, et al.. (2014). Role of miR-149C>T polymorphisms on the risk of hepatocellular carcinoma in a Chinese population. Genetics and Molecular Research. 13(3). 7184–7189. 13 indexed citations

19.

Zhang, Chun, Guoqiang Lv, Xianming Yu, et al.. (2011). Current evidence on the relationship between HRAS1 polymorphism and breast cancer risk: a meta-analysis. Breast Cancer Research and Treatment. 128(2). 467–472. 5 indexed citations

20.

Zhou, Ping‐Kun, Guoqiang Lv, Xianming Yu, et al.. (2010). Current evidence on the relationship between four polymorphisms in the matrix metalloproteinases (MMP) gene and breast cancer risk: a meta-analysis. Breast Cancer Research and Treatment. 127(3). 813–818. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact